Updated 7:47 a.m. yesterday

Quintiles earnings beat Street forecasts; CEO upbeat

Quintiles            Quintiles reports quarterly earnings that top Wall Street expectations, and the business pipeline has CEO Tom Pike upbeat. "We believe we are well-positioned for the long-term with our $12.04 billion of backlog," he says.

7:05 a.m. yesterday

Premium Lock News triggers seesaw day in robotic surgery tech firm TransEnterix

TransEnterix CEO Todd Pope Investors greet what on the surface appears to be good news for Triangle-based TransEnterix with a seesaw day of trading for the developer of robotic surgery technology. Does good news on FDA filing and capital funding end takeover rumors?

6:33 a.m. yesterday

Premium Lock FDA lifts 'hold' on trial, Heat Bio stock regains some lost value

Heat Biologics Shares in Heat Biologics regained some lost value Wednesday after the FDA lifted a "partial clinical hold" on a drug trial. The hold, which was announced last week, triggered a 25 percent plunge in Heat shares.

6:29 a.m. yesterday

'Humans + Software > Job Stealing Robots' - A point to remember

NEW logo The Institute for Emerging Issues at NCSU hosted a two-day Emerging Issues Forum earlier this week to explore what technology automation and robotics means for future workers. Jim Roberts, who leads the Network for Entrepreneurs in Wilmington (NEW), found much to be positive about.

5:46 a.m. yesterday

Solar backers try to allay NC lawmakers' fears about panel removal

Solar energy      Solar industry members and advocates told a legislative panel Wednesday there's little need to worry about the safe removal of solar panels in the state's future.

12:37 p.m. Wednesday

Feds refine 'driver;' Adwerx new ad product; Twitter tweaks timeline; Chinese want Opera

Bulldog In today's Bulldog wrapup of technology news: The government redefines "driver" in a boost for computer-controlled cars; Durham-based Adwerx launches new advertising product; Twitter tweaks its timeline; and Chinese investors offer $1.2B for Norwegian tech firm Opera.

12:24 p.m. Wednesday

Virginia-based CRO brings animal research facility to Triad

SoBran BioScience, a 500-employee contract research organization based in Fairfax, Va., will open a new animal research facility this summer in Greensboro, providing a bio-boost for the Triad.

Animal research facility coming to Triad Animal research facility coming to Triad

Updated 7:57 a.m. Wednesday

Thought leaders gather in Raleigh to create Internet of Things roadmap

Internet  A National Science Foundation-supported conference at NCSU over the next two days will explore the creation of a roadmap toward developing a national Internet of Things strategy. Here's a preview of what's going on.

7:08 a.m. Wednesday

Premium Lock What are top 3 disruptors in FinTech? Report makes the case

A new research report from Juniper breaks down what its analysts view as the top disruptors in the financial technical services, or FinTech, space. Our WTW Insider subscribers get a look at the top three.

Trying out Apple Pay Trying out Apple Pay

6:46 a.m. Wednesday

HQ Raleigh promising big news - Could it be Charlotte, Charleston expansion?

HQ Raleigh Does HQ Raleigh's Big News Involve Charlotte's Packard Place? A Charleston Campus? Similar messaging on social media by startup hubs in Raleigh and Charlotte hint at big news for the state's startup ecosystem this week.

6:36 a.m. Wednesday

'DJ Watson:' IBM's Watson joins Moogfest lineup

Moogest 2016 Watson will help Moogfest attendees compose their own songs, but there will be plenty of human performers, too, at the Durham event. New additions include synth-pop band Grimes and pop trio Mike Snow.

Tags: IBM, Internet
6:20 a.m. Wednesday

Report: SEC investigating former Salix executives

Salix        The former CEO and CFO of Salix Pharmaceuticals, which was sold to Valeant Pharmaceuticals for more than $11 billion a year ago, are being investigated by the SEC, according to the Reuters news service.

1:11 p.m. Tuesday

Premium Lock Novozymes reorganizes; changes may create some new jobs

Novozymes Novozymes, a global company focusing on enzyme development and production, is reorganizing. Its North America leader explains what's happening and says there will be some new jobs as a result.

12:54 p.m. Tuesday

NC IDEA launching next round of startup grant applications

NC IDEA NC IDEA will launch its next round of awarding up to $50,000 in non-dilutive grants to startups on Feb. 15. Entrepreneurs can learn more about the program at a series of state-wide meetings. and webinars.

12:07 p.m. Tuesday

Premium Lock Durham-based Chimerix reports progress in smallpox vaccine

Bioterror     Chimerix, which has a contract potentially worth more than $400 million in the development of a first vaccine targeting smallpox, reports progress in development of an antiviral. In recent tests, its brincidofovir successfully treated 100 percent of animals infected with rabbitpox.

11:42 a.m. Tuesday

Premium Lock Cognizant's growth throwing a 'cloud' over rivals IBM, Accenture

Analysis: Cognizant is increasingly encroaching on IBM and Accenture's territory by building out its consulting scale and digital and cloud expertise, writes Technology Business research Analyst Jennifer Hamel. Our Insiders get the full story.

Cloud computing Cloud computing

Updated 8:22 a.m. Tuesday

Jobless future? NC Science and Math robotics team remains gung ho

Amid the doom and gloom about a possible jobless future due to technology automation and robotics, a team of North Carolina School of Science and Mathematics - The Zebracorns - remain excited about the future.

Updated 7:32 a.m. Tuesday

Premium Lock Stampede! A 71% share wipeout for Biocryst after drug trial failure

Talk about a sell-off. Early Monday, Triangle-based Biocryst disclosed news that a drug candidate targeting a rare genetic condition had failed. The news set off an immediate plunge in its share price, triggered a Wall Street downgrade - and a possible lawsuit.

Biocryst plunges Biocryst plunges

6:50 a.m. Tuesday

Premium Lock Bob Ingram is new chair at Novan; Neal Hunter steps down

Novan Therapeutics Novan Therapeutics, a high-profile emerging pharmaceutical firm backed by big-name investors in the Triangle with a focus on developing new dermatology treatments, has a new chairman. But his name is a familiar one. Another well-known name leaves the board in the shuffle.

6:33 a.m. Tuesday

First person: 'How I pitched and won at Triangle Startup Weekend'

Exit Event From idea to market validation in 48 hours: A "Startup Weekend - Social Impact" story as written by Jason Parker for ExitEvent.


Latest for Insiders

Techwire Inside Partners